Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06543277 · ClinicalTrials.gov registry record · NA
Safety and Feasibility of Paired Transcutaneous Auricular Vagus Nerve Stimulation (taVNS) With Upper Limb Rehabilitation in Incomplete Spinal Cord Injury
A NA study of Chronic Incomplete Cervical Spinal Cord Injury (SCI), sponsored by The University of Texas Health Science Center, Houston.
- Recruiting
- Registry status
- NA
- Development phase
- 12
- Enrollment target
- 2
- Study locations
NCT06543277: Recruiting NA study of Chronic Incomplete Cervical Spinal Cord Injury (SCI), sponsored by The University of Texas Health Science Center, Houston.
NCT06543277 is a NA study of Chronic Incomplete Cervical Spinal Cord Injury (SCI) that is actively recruiting participants, run by The University of Texas Health Science Center, Houston. The registered enrollment target is 12 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06543277, a NA study of Chronic Incomplete Cervical Spinal Cord Injury (SCI), is actively recruiting participants, sponsored by The University of Texas Health Science Center, Houston.
- RECRUITING
- Registry status
- NA
- Development phase
- 12 participants
- Enrollment target
- 2
- Study locations
Study Summary
The purpose of this study is to evaluate the safety and feasibility of transcutaneous auricular Vagus Nerve Stimulation (taVNS) paired with upper-limb rehabilitation in adults with tetraplegia caused by cervical spinal cord injury.
Conditions Studied
Interventions
- DEVICE Transcutaneous Auricular Vagus Nerve Stimulation (taVNS)
Study Locations (2)
Texas
- Neurorecovery Research Center, TIRR MHH - Houston
- The University of Texas Health Science Center at Houston - Houston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 12 participants |
| Start Date | 2025-08-15 |
| Est. Completion | 2027-12-30 |
| Phase | NA |
What NCT06543277 shows while recruiting
NCT06543277 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 12 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 1 condition, with Chronic Incomplete Cervical Spinal Cord Injury (SCI) appearing as the primary indexed condition, and to 1 intervention - of which Transcutaneous Auricular Vagus Nerve Stimulation (taVNS) is the first listed.
NCT06543277 reports a single indexed study location in Texas.
Frequently Asked Questions
What is clinical trial NCT06543277 about?
NCT06543277 is a clinical study titled "Safety and Feasibility of Paired Transcutaneous Auricular Vagus Nerve Stimulation (taVNS) With Upper Limb Rehabilitation in Incomplete Spinal Cord Injury". The purpose of this study is to evaluate the safety and feasibility of transcutaneous auricular Vagus Nerve Stimulation (taVNS) paired with upper-limb rehabilitation in adults with tetraplegia caused by cervical spinal cord injury.
What is the current status of trial NCT06543277?
This trial is currently recruiting. It is a NA study. The enrollment target is 12 participants. The study started on 2025-08-15. Estimated completion is 2027-12-30.
What conditions does trial NCT06543277 study?
This clinical trial studies the following conditions: Chronic Incomplete Cervical Spinal Cord Injury (SCI).
What interventions are being tested in trial NCT06543277?
The interventions under investigation include: Transcutaneous Auricular Vagus Nerve Stimulation (taVNS) (DEVICE).
Who is sponsoring clinical trial NCT06543277?
This trial is sponsored by The University of Texas Health Science Center, Houston, which has 732 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06543277 being conducted?
This trial has 2 study locations across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT06543277's enrollment target sits among peer trials
12 1914th of 2000 higher than 74 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02602769 · 12 participants
Whole Transcriptome Profiling and Metabolic Phenotyping in Children With ROHHAD Syndrome
- NCT02605421 · 12 participants · Phase 2
Myeloablative Consolidation Therapy and Tandem Autologous Stem Cell Rescue in Patients With High-Risk Neuroblastoma
- NCT02619448 · 12 participants · Early Phase 1
Concurrent Chemotherapy Plus HFR Radiation Therapy in Inoperable NSCLC
- NCT03311503 · 12 participants · Phase 1
Phase I/II Trial of Lentiviral Gene Transfer for SCID-X1 With Low Dose Targeted Busulfan Conditioning
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI